AABB

Your lab deserves strong leadership. AABB can help. AABB’s Leadership Certificate in Blood Banking and Transfusion Medicine equips current and emerging lab supervisors with the skills to lead with confidence and impact. What you’ll gain: 🔹 27 interactive online modules covering seven essential leadership domains 🔹 Self-paced learning with expert guidance and industry-standard training 🔹 Limited-time 25% discount for AABB members with promocode LEADER25 (through Dec. 31) Invest in your growth, strengthen your team and transform your lab. Learn more and enroll: https://bit.ly/4qbBf48 #BloodBanking #Transfusion #MedLab

After attending more than 40 AABB Annual Meetings, Laurie Munk, AABB's senior director of publications, has seen it all — and learned how to get the most from every minute. In a new article, Laurie shares practical insights on planning your schedule, connecting with colleagues and maximizing your Annual Meeting experience. Read the full piece: https://bit.ly/4nJ0uJz #AABB2025 #BloodBanking #Transfusion #Biotherapies

Viscoelastic testing in patient blood management: friend or foe? 🩸 In the latest PBM Column, Mark Friedman, DO, from NYU Langone Health, examines the use of viscoelastic testing (VET) in assessing hemostasis, its application in various clinical settings and the evidence supporting its role in patient blood management. Access the full column and explore additional PBM resources: https://bit.ly/4q8gcQc #Transfusion #PBM 

New in #Transfusion: Researchers from across the blood community reviewed data from the Transfusion-Transmissible Infections Monitoring System (TTIMS), which tracks trends in ~60% of the U.S. blood supply, to examine how reducing donor deferral periods for certain risk behaviors affected HIV, HBV and HCV prevalence. Here’s what they found: ✅ HIV prevalence: 2.5 → 2.0 per 100,000 donations. ✅ HBV prevalence: 6.5 → 6.2 per 100,000 donations. ✅ HCV prevalence: 19.7 → 9.6 per 100,000 donations. The bottom line: Shorter donor deferrals did not compromise the safety of the U.S. blood supply. Read the full study: https://bit.ly/4qhMWqe #BloodSupply #BloodSafety

At the AABB Foundation, driving innovation is in our blood. 🩸 Since 1983, supporters of the Foundation have funded more than 200 early-career researchers in blood and biotherapies, unlocking discoveries that change lives. Now you can be part of this movement. Join the AABB Foundation’s Run for Research at #AABB2025 in San Diego. Whether you run, walk, or sleep in, your participation supports the next generation of innovators. Register today: https://bit.ly/46ovQh3 #AABBFoundation

The last time AABB met in San Diego, the blood and biotherapies community was turning the page on the Zika virus outbreak, the Food and Drug Administration had just approved the first two CAR T-cell therapies, and “individual donor assessment” was just an idea. Our field looks different today. We’ve unlocked new therapies, welcomed new donors and charted new ways to change lives. A lot has changed, but one thing never does: The AABB Annual Meeting is where our community comes together to turn ideas into action. The next chapter starts in two weeks. See you at #AABB2025.✨

Get an advanced look at the practice-changing research taking center stage at #AABB2025! The 2025 Annual Meeting abstracts are now available in an online supplement to the September issue of Transfusion. See what’s in store: https://bit.ly/46HBcpg #Transfusion #Biotherapies #Research

A new class of biotherapies leaders is transforming advanced therapies. Our newest case study shows how. Get to know six professionals who earned AABB’s certified advanced biotherapies professional (CABP) credential and see how it’s shaping their work, their organizations, and the field. Featuring insights from: 🔹 Linda Peltier, PhD, RN, CABP 🔹 Amanda Medcalf Conerty, CABP 🔹 Siddharth Krishnan, MS, MBA, CABP 🔹 Jared Schuster, HTL(ASCP), CABP 🔹 Gaurav Gupta, MD, PhD, CABP 🔹 Kevin Land MD, CABP Read the full case study and explore whether the CABP credential is right for you or your team: https://bit.ly/4q2Nkc6 #AABBcabp #Biotherapies #CellTherapy #AdvancedTherapies

What’s on your mind? 💡 At this year’s AABB Annual Meeting, AABB is hosting an interactive roundtable session where you bring the questions. Attendees will sit down with peers and expert facilitators to explore the hottest topics in transfusion medicine and biotherapies. We’re building the list of table topics now, and we want your input! A few ideas to get you started: 🔹 Managing sickle cell patients and transfusion support 🔹 Prehospital transfusion implementation 🔹 Staff competency and quality systems essentials 🔹 Management of patients at risk of HDFN 🔹 Pediatric and neonatal transfusion practices What challenges or hot topics do you want to discuss with colleagues? Drop your suggestions in the comments and help shape one of the most engaging sessions of the meeting. #AABB2025 #Transfusion #BloodBanking #Biotherapies

Thousands of attendees, thousands of reasons to attend the AABB Annual Meeting! 💡 For Chloe Homich, MLS(ASCP)SBB, CQA(ASQ), it’s more than a meeting. It’s experience that keeps her coming back. Read our latest AABB News article to find out why: https://bit.ly/48wJNMT #Transfusion #BloodBanking #Biotherapies #AABB2025